[Congressional Record Volume 166, Number 117 (Thursday, June 25, 2020)]
[Senate]
[Page S3415]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 1935. Mr. PETERS submitted an amendment intended to be proposed by 
him to the bill S. 4049, to authorize appropriations for fiscal year 
2021 for military activities of the Department of Defense, for military 
construction, and for defense activities of the Department of Energy, 
to prescribe military personnel strengths for such fiscal year, and for 
other purposes; which was ordered to lie on the table; as follows:

       At the end of subtitle C of title VII, add the following:

     SEC. 7__. STUDY ON HEALTH READINESS CONTRACTS OF DEPARTMENT 
                   OF DEFENSE TO ASSESS RELIANCE ON FOREIGN 
                   SOURCES OF ACTIVE PHARMACEUTICAL INGREDIENTS, 
                   DRUGS, AND MEDICAL DEVICES.

       (a) Study on Health Readiness Contracts.--Not later than 18 
     months after the date of the enactment of this Act, the 
     Director of the Defense Logistics Agency shall submit to the 
     Committees on Armed Services of the Senate and the House of 
     Representatives the results of a study on contracts entered 
     into by the Director relating to health readiness of the 
     Armed Forces to assess--
       (1) the reliance by the Department of Defense on foreign 
     sources of active pharmaceutical ingredients, drugs, and 
     medical devices; and
       (2) the redundancy planning of the Department to mitigate 
     shortages of drugs and medical devices.
       (b) Definitions.-- In this section:
       (1) Drug.--The term ``drug'' has the meaning given that 
     term in section 201 of the Federal Food, Drug, and Cosmetic 
     Act (21 U.S.C. 321).
       (2) Medical device.--The term ``medical device'' has the 
     meaning given the term ``device'' in such section 201.
                                 ______